Copyright Reports & Markets. All rights reserved.

Global Digital Diagnostics Market Size, Status and Forecast 2019-2025

Buy now
  • 1.1 Research Scope
  • 1.2 Market Segmentation
  • 1.3 Research Objectives
  • 1.4 Research Methodology
    • 1.4.1 Research Process
    • 1.4.2 Data Triangulation
    • 1.4.3 Research Approach
    • 1.4.4 Base Year
  • 1.5 Coronavirus Disease 2019 (Covid-19) Impact Will Have a Severe Impact on Global Growth
    • 1.5.1 Covid-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections
    • 1.5.2 Covid-19 Impact: Commodity Prices Indices
    • 1.5.3 Covid-19 Impact: Global Major Government Policy
  • 1.6 The Covid-19 Impact on Digital Diagnostics Industry
  • 1.7 COVID-19 Impact: Digital Diagnostics Market Trends
  • 2 Global Digital Diagnostics Quarterly Market Size Analysis

    • 2.1 Digital Diagnostics Business Impact Assessment - COVID-19
      • 2.1.1 Global Digital Diagnostics Market Size, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026
    • 2.2 Global Digital Diagnostics Quarterly Market Size 2020-2021
    • 2.3 COVID-19-Driven Market Dynamics and Factor Analysis
      • 2.3.1 Drivers
      • 2.3.2 Restraints
      • 2.3.3 Opportunities
      • 2.3.4 Challenges

    3 Quarterly Competitive Assessment, 2020

    • 3.1 By Players, Global Digital Diagnostics Quarterly Market Size, 2019 VS 2020
    • 3.2 By Players, Digital Diagnostics Headquarters and Area Served
    • 3.3 Date of Key Players Enter into Digital Diagnostics Market
    • 3.4 Key Players Digital Diagnostics Product Offered
    • 3.5 Mergers & Acquisitions, Expansion Plans

    4 Impact of Covid-19 on Digital Diagnostics Segments, By Type

    • 4.1 Introduction
      • 1.4.1 HxM BT, HxM Smart, and BioHarness 3
      • 1.4.2 BioStampRC
      • 1.4.3 HealthPatch MD
      • 1.4.4 IBrain
      • 1.4.5 Intelligent Breast Exam (iBE)
      • 1.4.6 Midmark IQvitals, IQecg, IQholter, IQspiro and Iqstress
      • 1.4.7 Cerora Borealis
      • 1.4.8 Qardioarm, Qardiobase, and Qardiocore
      • 1.4.9 VitalPatch
      • 1.4.10 Others
    • 4.2 By Type, Global Digital Diagnostics Market Size, 2019-2021

    5 Impact of Covid-19 on Digital Diagnostics Segments, By Application

    • 5.1 Overview
      • 5.5.1 Hospitals
      • 5.5.2 Research Laboratories
      • 5.5.3 Contract Research Organizations
      • 5.5.4 Others
    • 5.2 By Application, Global Digital Diagnostics Market Size, 2019-2021
      • 5.2.1 By Application, Global Digital Diagnostics Market Size by Application, 2019-2021

    6 Geographic Analysis

    • 6.1 Introduction
    • 6.2 North America
      • 6.2.1 Macroeconomic Indicators of US
      • 6.2.2 US
      • 6.2.3 Canada
    • 6.3 Europe
      • 6.3.1 Macroeconomic Indicators of Europe
      • 6.3.2 Germany
      • 6.3.3 France
      • 6.3.4 UK
      • 6.3.5 Italy
    • 6.4 Asia-Pacific
      • 6.4.1 Macroeconomic Indicators of Asia-Pacific
      • 6.4.2 China
      • 6.4.3 Japan
      • 6.4.4 South Korea
      • 6.4.5 India
      • 6.4.6 ASEAN
    • 6.5 Rest of World
      • 6.5.1 Latin America
      • 6.5.2 Middle East and Africa

    7 Company Profiles

    • 7.1 Biomeme
      • 7.1.1 Biomeme Business Overview
      • 7.1.2 Biomeme Digital Diagnostics Quarterly Revenue, 2020
      • 7.1.3 Biomeme Digital Diagnostics Product Introduction
      • 7.1.4 Biomeme Response to COVID-19 and Related Developments
    • 7.2 Fever Smart
      • 7.2.1 Fever Smart Business Overview
      • 7.2.2 Fever Smart Digital Diagnostics Quarterly Revenue, 2020
      • 7.2.3 Fever Smart Digital Diagnostics Product Introduction
      • 7.2.4 Fever Smart Response to COVID-19 and Related Developments
    • 7.3 Qardio
      • 7.3.1 Qardio Business Overview
      • 7.3.2 Qardio Digital Diagnostics Quarterly Revenue, 2020
      • 7.3.3 Qardio Digital Diagnostics Product Introduction
      • 7.3.4 Qardio Response to COVID-19 and Related Developments
    • 7.4 MidMark Corp
      • 7.4.1 MidMark Corp Business Overview
      • 7.4.2 MidMark Corp Digital Diagnostics Quarterly Revenue, 2020
      • 7.4.3 MidMark Corp Digital Diagnostics Product Introduction
      • 7.4.4 MidMark Corp Response to COVID-19 and Related Developments
    • 7.5 Cerora
      • 7.5.1 Cerora Business Overview
      • 7.5.2 Cerora Digital Diagnostics Quarterly Revenue, 2020
      • 7.5.3 Cerora Digital Diagnostics Product Introduction
      • 7.5.4 Cerora Response to COVID-19 and Related Developments
    • 7.6 Neurovigil
      • 7.6.1 Neurovigil Business Overview
      • 7.6.2 Neurovigil Digital Diagnostics Quarterly Revenue, 2020
      • 7.6.3 Neurovigil Digital Diagnostics Product Introduction
      • 7.6.4 Neurovigil Response to COVID-19 and Related Developments
    • 7.7 Medtronic
      • 7.7.1 Medtronic Business Overview
      • 7.7.2 Medtronic Digital Diagnostics Quarterly Revenue, 2020
      • 7.7.3 Medtronic Digital Diagnostics Product Introduction
      • 7.7.4 Medtronic Response to COVID-19 and Related Developments
    • 7.8 UE LifeSciences
      • 7.8.1 UE LifeSciences Business Overview
      • 7.8.2 UE LifeSciences Digital Diagnostics Quarterly Revenue, 2020
      • 7.8.3 UE LifeSciences Digital Diagnostics Product Introduction
      • 7.8.4 UE LifeSciences Response to COVID-19 and Related Developments
    • 7.9 Vital Connect
      • 7.9.1 Vital Connect Business Overview
      • 7.9.2 Vital Connect Digital Diagnostics Quarterly Revenue, 2020
      • 7.9.3 Vital Connect Digital Diagnostics Product Introduction
      • 7.9.4 Vital Connect Response to COVID-19 and Related Developments
    • 7.10 MC10
      • 7.10.1 MC10 Business Overview
      • 7.10.2 MC10 Digital Diagnostics Quarterly Revenue, 2020
      • 7.10.3 MC10 Digital Diagnostics Product Introduction
      • 7.10.4 MC10 Response to COVID-19 and Related Developments
    • 7.11 CellScope
      • 7.11.1 CellScope Business Overview
      • 7.11.2 CellScope Digital Diagnostics Quarterly Revenue, 2020
      • 7.11.3 CellScope Digital Diagnostics Product Introduction
      • 7.11.4 CellScope Response to COVID-19 and Related Developments
    • 7.12 Oxitone Medical
      • 7.12.1 Oxitone Medical Business Overview
      • 7.12.2 Oxitone Medical Digital Diagnostics Quarterly Revenue, 2020
      • 7.12.3 Oxitone Medical Digital Diagnostics Product Introduction
      • 7.12.4 Oxitone Medical Response to COVID-19 and Related Developments
    • 7.13 Sigma-Aldrich Corporation
      • 7.13.1 Sigma-Aldrich Corporation Business Overview
      • 7.13.2 Sigma-Aldrich Corporation Digital Diagnostics Quarterly Revenue, 2020
      • 7.13.3 Sigma-Aldrich Corporation Digital Diagnostics Product Introduction
      • 7.13.4 Sigma-Aldrich Corporation Response to COVID-19 and Related Developments
    • 7.14 Bio SB
      • 7.14.1 Bio SB Business Overview
      • 7.14.2 Bio SB Digital Diagnostics Quarterly Revenue, 2020
      • 7.14.3 Bio SB Digital Diagnostics Product Introduction
      • 7.14.4 Bio SB Response to COVID-19 and Related Developments
    • 7.15 Sakura Finetek Japan
      • 7.15.1 Sakura Finetek Japan Business Overview
      • 7.15.2 Sakura Finetek Japan Digital Diagnostics Quarterly Revenue, 2020
      • 7.15.3 Sakura Finetek Japan Digital Diagnostics Product Introduction
      • 7.15.4 Sakura Finetek Japan Response to COVID-19 and Related Developments

    8 Key Findings

      9 Appendix

      • 9.1 About US

      This report covers market size and forecasts of Digital Diagnostics, including the following market information:
      Global Digital Diagnostics Market Size, 2019-2021, and 2020 (quarterly data), (US$ Million)
      Global Digital Diagnostics Market Size by Type and by Application, 2019-2021, and 2020 (quarterly data), (US$ Million)
      Global Digital Diagnostics Market Size by Region (and Key Countries), 2019-2021, and 2020 (quarterly data), (US$ Million)
      Global Digital Diagnostics Market Size by Company, 2019- 2020 (quarterly data), (US$ Million)

      Key market players
      Major competitors identified in this market include Biomeme, Fever Smart, Qardio, MidMark Corp, Cerora, Neurovigil, Medtronic, UE LifeSciences, Vital Connect, MC10, CellScope, Oxitone Medical, Sigma-Aldrich Corporation, Bio SB, Sakura Finetek Japan, etc.

      Based on the Region:
      Asia-Pacific (China, Japan, South Korea, India and ASEAN)
      North America (US and Canada)
      Europe (Germany, France, UK and Italy)
      Rest of World (Latin America, Middle East & Africa)

      Based on the Type:
      HxM BT, HxM Smart, and BioHarness 3
      BioStampRC
      HealthPatch MD
      IBrain
      Intelligent Breast Exam (iBE)
      Midmark IQvitals, IQecg, IQholter, IQspiro and Iqstress
      Cerora Borealis
      Qardioarm, Qardiobase, and Qardiocore
      VitalPatch
      Others

      Based on the Application:
      Hospitals
      Research Laboratories
      Contract Research Organizations
      Others

      Buy now